FDA Issues Warning Letter to OTC Drug Manufacturer For Data Integrity Concerns
August 21st 2019The FDA has published a warning letter sent to Ningbo Huize Commodity, an over-the-counter drug manufacturer, citing significant current good manufacturing practice (CGMP) violations including data integrity issues.
Read More
Survey: Customer Satisfaction With Pharmacists Remain High
August 21st 2019Despite e-commerce disruptions to the industry, a recent study found that the United States pharmacy industry continues to maintain high levels of customer satisfaction in both the brick-and-mortar and mail order segments.
Read More
New Treatment for Rheumatoid Arthritis Granted FDA Approval
August 19th 2019Officials with the FDA have approved AbbVie’s upadacitinib (Rinvoq) 15 mg, once-daily oral Janus kinase (JAK) inhibitor, for the treatment of adults with moderately to severely active rheumatoid arthritis (RA) who have had an inadequate response or intolerance to methotrexate (MTX-IR).
Read More
FDA Approves Fenofibrate Product for Treating Certain Cholesterol Conditions
August 14th 2019Officials with the FDA have approved Alembic Pharmaceuticals’ Fenofibrate Tablets USP, 48 mg and 145 mg as an adjunctive therapy to diet to reduce elevated low-density lipoprotein cholesterol (LDL-C), total cholesterol (Total-C), Triglycerides and apolipoprotein B (Apo B).
Read More